Speciality Therapeutics Limited - Company Profile

It is a healthcare public limited company based in Mumbai, Maharashtra, India, established in 2019.

2019 Mumbai, Maharashtra, India Struck Off

Last Updated: July 26, 2025

About Speciality Therapeutics Limited

Speciality Therapeutics Limited, a struck off public limited company, was established on 06 May 2019 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U33309MH2019PLC324955. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.70 K .

Its leadership includes Hoshmand Jal Bamji (Director), Jayshree Ramasubramanian (Director), Alok Dayanand Sureka (Additional Director). Past directors included Dibakar Satyabrata Chatterjee, Bhushan Sharad Punekar, Hoshmand Jal Bamji. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 47 A To Z Industrial Estate, Ganpatrao Kadam Marg, Lower Parel (W),, Mumbai, Maharashtra, 400013.

Company Details

CIN/LLPIN
U33309MH2019PLC324955
Registration Number
324955
Incorporation Date
06 May 2019
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.70 K
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 0.50 M as on 26-07-2025
Paid Up Capital ₹ 0.70 K as on 26-07-2025
Company Age 6 Year, 10 Months
Last Filing with ROC 31 Mar 2020

Comprehensive Company Insights

Explore comprehensive insights into Speciality Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Speciality Therapeutics Limited?

Current Directors

Name	Designation	Appointment Date	Status
Hoshmand Jal Bamji	Director	07 Nov 2019	Current
Jayshree Ramasubramanian	Director	06 May 2019	Current
Alok Dayanand Sureka	Additional Director	23 Feb 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	12 Dec 2019	Past
Pramod Abcsdd	Director	23 Feb 2022	Past
Pramod Abcsdd	Additional Director	31 Dec 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Speciality Therapeutics.

Speciality Therapeutics Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Speciality Therapeutics?

Unlock access to Speciality Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Speciality Therapeutics?

Unlock and access historical data on people associated with Speciality Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Speciality Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Speciality Therapeutics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Speciality Therapeutics

Recent Activity within the Organization

Director Appointment

The activity Alok Dayanand Sureka was appointed as a Additional Director was appointed as a Additional Director on 23 Feb 2022 & has been associated with this company since 4 years 1 month . was completed.
23 Feb 2022
Annual General Meeting

Progress on Speciality Therapeutics Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.
31 Dec 2020
Balance Sheet

Progress on Speciality Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was documented.
31 Mar 2020
Director Appointment

Progress on Hoshmand Jal Bamji was appointed as a Director was appointed as a Director on 07 Nov 2019 & has been associated with this company since 6 years 4 months . was documented.
07 Nov 2019
Director Appointment

Jayshree Ramasubramanian was appointed as a Director was appointed as a Director on 06 May 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
06 May 2019
Company Incorporation

The activity Speciality Therapeutics Limited was registered on 06 May 2019 with Roc Mumbai & aged 6 years 10 months as per MCA records. was completed.
06 May 2019

Explore recent activity and updates - View Recent Activity